|
LOC728190 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.60940150095712E-11 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.22849952433057E-10 |
| Normal-vs-Stage2 |
8.92399999452564E-08 |
| Normal-vs-Stage3 |
2.65565347490337E-13 |
| Normal-vs-Stage4 |
1.31380462065067E-11 |
| Stage1-vs-Stage2 |
7.529000E-01 |
| Stage1-vs-Stage3 |
6.435300E-03 |
| Stage1-vs-Stage4 |
1.307760E-01 |
| Stage2-vs-Stage3 |
4.186200E-02 |
| Stage2-vs-Stage4 |
1.651820E-01 |
| Stage3-vs-Stage4 |
5.801000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.99182900675987E-12 |
| Normal-vs-AfricanAmerican |
1.537330E-03 |
| Normal-vs-Asian |
7.44579953249058E-10 |
| Caucasian-vs-AfricanAmerican |
8.559300E-03 |
| Caucasian-vs-Asian |
5.780400E-01 |
| AfricanAmerican-vs-Asian |
6.479700E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.42199593714076E-11 |
| Normal-vs-Female |
2.41260345035244E-11 |
| Male-vs-Female |
6.232000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.09919970295402E-10 |
| Normal-vs-Age(41-60Yrs) |
3.11994874380161E-12 |
| Normal-vs-Age(61-80Yrs) |
4.99600028014413E-10 |
| Normal-vs-Age(81-100Yrs) |
2.356700E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.014400E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.631800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.775800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.025000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.790400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.033000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.622200E-03 |
| Classical-VS-Follicular |
9.968600E-04 |
| Classical-VS-Other |
1.985980E-01 |
| Classical-VS-Normal |
2.19150253499834E-11 |
| Tall-VS-Follicular |
1.82561999999553E-05 |
| Tall-VS-Other |
7.640500E-03 |
| Tall-VS-Normal |
1.83408843668076E-12 |
| Follicular-VS-Other |
8.986200E-01 |
| Follicular-VS-Normal |
1.17120000031612E-07 |
| Other-VS-Normal |
3.342500E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.17580389868976E-11 |
| Normal-vs-N1 |
1.84209980602645E-10 |
| N0-vs-N1 |
6.634400E-01 |
|
|
